Last: | $3.44 |
---|---|
Change Percent: | 0.0% |
Open: | $3.46 |
Close: | $3.44 |
High: | $3.485 |
Low: | $3.365 |
Volume: | 800,057 |
Last Trade Date Time: | 05/31/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.44 | $3.46 | $3.44 | $3.485 | $3.365 | 800,057 | 05-31-2024 |
$3.46 | $3.55 | $3.46 | $3.58 | $3.46 | 936,453 | 05-30-2024 |
$3.52 | $3.46 | $3.52 | $3.53 | $3.4 | 867,173 | 05-29-2024 |
$3.54 | $3.5 | $3.54 | $3.57 | $3.483 | 870,755 | 05-28-2024 |
$3.46 | $3.48 | $3.46 | $3.52 | $3.44 | 385,957 | 05-27-2024 |
$3.46 | $3.48 | $3.46 | $3.52 | $3.44 | 385,957 | 05-24-2024 |
$3.47 | $3.61 | $3.47 | $3.62 | $3.43 | 781,818 | 05-23-2024 |
$3.57 | $3.51 | $3.57 | $3.63 | $3.44 | 905,093 | 05-22-2024 |
$3.52 | $3.59 | $3.52 | $3.65 | $3.49 | 945,311 | 05-21-2024 |
$3.62 | $3.35 | $3.62 | $3.63 | $3.3375 | 1,464,893 | 05-20-2024 |
$3.37 | $3.34 | $3.37 | $3.41 | $3.3 | 805,264 | 05-17-2024 |
$3.32 | $3.4 | $3.32 | $3.41 | $3.26 | 811,820 | 05-16-2024 |
$3.4 | $3.43 | $3.4 | $3.515 | $3.16 | 2,138,334 | 05-15-2024 |
$3.4 | $3.48 | $3.4 | $3.63 | $3.4 | 1,147,226 | 05-14-2024 |
$3.42 | $3.47 | $3.42 | $3.66 | $3.3 | 1,698,892 | 05-13-2024 |
$3.51 | $3.7 | $3.51 | $3.7 | $3.44 | 1,292,183 | 05-10-2024 |
$3.74 | $3.23 | $3.74 | $3.76 | $3.01 | 2,272,856 | 05-09-2024 |
$4.26 | $4.25 | $4.26 | $4.31 | $4.16 | 1,157,428 | 05-08-2024 |
$4.28 | $4.45 | $4.28 | $4.52 | $4.28 | 623,894 | 05-07-2024 |
$4.52 | $4.55 | $4.52 | $4.68 | $4.51 | 611,341 | 05-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Advantage Solutions Inc. Company Name:
ADV Stock Symbol:
NASDAQ Market:
Shares of Duolingo, Inc. (NASDAQ:DUOL) fell sharply during Thursday's session after the company reported first quarter financial results. Duol...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Management reaffirms its 2024 outlook as first-quarter results met expectations despite soft market conditions and higher-than-expected costs and investments. Inclusive of discontinued operations, revenues were $906 million, a 10% decline compared to the prior year and an increase of 1% when ...